The Huberman Lab
The Huberman Lab

Female Hormone Health, PCOS, Endometriosis, Fertility & Breast Cancer | Dr. Thaïs Aliabadi

My guest is Dr. Thaïs Aliabadi, MD, board-certified OB/GYN, surgeon and leading expert in women's health. We discuss polycystic ovary syndrome (PCOS) and endometriosis, two very common yet frequently undiagnosed causes of female infertility. Dr. Aliabadi explains the symptoms, underlying causes

Featured Speakers

Scicomm Media Host

Topics Discussed

Episode Summary

Executive Summary: Dr. Tais Ali Abadi discusses the systemic dismissal of women's health issues, particularly PCOS and endometriosis, which are the leading causes of infertility yet remain largely undiagnosed. She provides a comprehensive overview of PCOS, including its four phenotypes, underlying drivers (insulin resistance, inflammation, genetics), and actionable treatments from lifestyle changes to supplements, metformin, and GLP-1s. She explains endometriosis as a debilitating condition where uterine-like tissue grows outside the uterus, causing pain and infertility, and emphasizes the need for proper diagnosis through patient history and laparoscopic surgery. She also stresses the importance of knowing one's lifetime breast cancer risk using the Tyrer-Cuzick tool and advocates for a complete well-woman exam that includes pelvic ultrasound, egg count (AMH) testing, and hormonal assessment.

Main Topics: Systemic dismissal of women's health symptoms: Dr. Ali Abadi highlights that women's symptoms are routinely minimized, normalized, or dismissed, leading to delayed diagnosis of conditions like PCOS and endometriosis. She compares this to a patient with cataracts being told they are crazy. PCOS diagnosis, phenotypes, and underlying drivers: PCOS affects 15-20% of women, but over 90% go undiagnosed. The condition has four phenotypes and is driven by brain-pituitary-ovary axis dysfunction, insulin resistance, inflammation, genetics, and epigenetics. Diagnosis requires two of three criteria: high androgen symptoms, ovulation dysfunction, and PCOS-looking ovaries on ultrasound or elevated AMH. Treatments for PCOS and fertility optimization: Treatment involves addressing insulin resistance through lifestyle changes, supplements (inositol, vitamin D, chromium), metformin, and GLP-1s. For fertility, letrozole or clomiphene can induce ovulation, and egg freezing before age 30 is recommended. Over 50% of PCOS patients also have endometriosis, which must be treated concurrently. Endometriosis diagnosis, impact, and treatment: Endometriosis affects an estimated 20%+ of women, takes 9-11 years to diagnose, and is the leading cause of infertility. Symptoms include painful periods, painful sex, bloating, and chronic pelvic pain. The gold standard treatment is laparoscopic excision of lesions followed by hormonal suppression with progesterone IUDs, birth control, or GnRH antagonists. Breast cancer risk assessment and early detection: Every woman should know her lifetime risk of breast cancer using the Tyrer-Cuzick tool. Those with 20%+ risk should start breast imaging at age 30, not 40. Dr. Ali Abadi shares her personal story of diagnosing her own breast cancer after calculating her 37% risk, despite having no family history or genetic mutations. Comprehensive well-woman exam and fertility evaluation: A proper well-woman exam should include pelvic ultrasound, AMH testing, hormone panel, and assessment for PCOS, endometriosis, and autoimmune conditions. Dr. Ali Abadi presents a "bucket" approach to infertility evaluation: female factor, male factor, tubal/anatomy, endometriosis, PCOS, and autoimmune.

Key Arguments: Women's symptoms are routinely dismissed, minimized, or normalized, leading to delayed diagnosis of PCOS and endometriosis, which are the leading causes of infertility. PCOS is not just about ovarian cysts; it has four phenotypes and requires meeting two of three diagnostic criteria, not all three. Insulin resistance is a core driver of PCOS, and addressing it through supplements, metformin, or GLP-1s can significantly improve symptoms and fertility. Endometriosis can be diagnosed 99% accurately just by listening to the patient's history, yet it takes 9-11 years and multiple doctor visits to diagnose. Laparoscopic excision is the gold standard for treating endometriosis, but very few gynecologists are trained to do it properly. Knowing your lifetime risk of breast cancer using the Tyrer-Cuzick tool is non-negotiable, and high-risk women (20%+) should start screening at age 30. OB/GYN should be separated from obstetrics to allow gynecologists to focus on diagnosing and treating conditions like PCOS, endometriosis, and hormonal issues. Most cases of unexplained infertility are actually undiagnosed PCOS and/or endometriosis.

Data Points: PCOS prevalence: 15% of women in the US, over 20% in Middle Eastern countries - Most common hormone disorder in reproductive-age women PCOS underdiagnosis: Over 90% are never diagnosed - Studies show 70%, but Dr. Ali Abadi believes it's now over 90% Endometriosis diagnosis delay: 9 to 11 years - Average time to diagnose endometriosis Endometriosis prevalence: Over 20% (estimated) - Commonly cited as 10%, but Dr. Ali Abadi believes it's north of 20% Average lifetime risk of breast cancer: 12.5% - Average American woman's lifetime risk High-risk threshold for breast cancer: 20% or more - Women at 20%+ lifetime risk should start imaging at age 30 PCOS patients who also have endometriosis: Over 50% - Dr. Ali Abadi's clinical observation PCOS patients who don't ovulate: 70 to 80% - Even those with regular cycles may not ovulate Average weight loss on GLP-1s in 4 months: 24 pounds - Dr. Ali Abadi's clinical data since 2014 Counties in the US without an OB/GYN: 50% - Half of US counties lack access to an OB/GYN

Pivotal Quotes: "Women's health is very different than other fields of medicine. It's a different monster. It's that cataract patient that goes to 20 ophthalmologists and she keeps saying, 'I can't see.' And the ophthalmologist says, 'You're crazy. There's nothing wrong with you.'" — Dr. Tais Ali Abadi: On the systematic dismissal of women's health symptoms "Your genes load the gun, your environment pulls the trigger." — Dr. Tais Ali Abadi: Explaining the interaction between genetics and epigenetics in PCOS "If men had a condition that would cause them to have severe pain during sex, scar their scrotums, lower their sperm count, be the top cause of their infertility, stay home two to three days a month in bed, end up in emergency rooms, do you think the majority of them would go undiagnosed?" — Dr. Tais Ali Abadi: On the gender bias in medical attention for reproductive health conditions

Implications: This episode empowers women to advocate for their health by providing actionable diagnostic criteria and treatment pathways for PCOS and endometriosis. Listeners are armed with knowledge to challenge dismissive doctors, request specific tests (pelvic ultrasound, AMH, breast cancer risk assessment), and pursue evidence-based treatments. The conversation calls for a systemic overhaul in women's healthcare, including separating OB from GYN, mandating pelvic ultrasounds, and shifting the narrative from 'it's in your head' to 'your symptoms are real.'

🔓 Sign Up for Unlimited Episode Search

About The Huberman Lab

The Huberman Lab podcast is hosted by Andrew Huberman, Ph.D., a neuroscientist and tenured professor in the department of neurobiology, and by courtesy, psychiatry and behavioral sciences at Stanford School of Medicine. The podcast discusses neuroscience and science-based tools, including how our brain and its connections with the organs of our body control our perceptions, our behaviors, and our health, as well as existing and emerging tools for measuring and changing how our nervous system works. Huberman has made numerous significant contributions to the fields of brain development, brain function, and neural plasticity, which is the ability of our nervous system to rewire and learn new behaviors, skills, and cognitive functioning. He is a McKnight Foundation and Pew Foundation Fellow and was awarded the Cogan Award, given to the scientist making the most significant discoveries in the study of vision, in 2017. Work from the Huberman Laboratory at Stanford School of Medicine has been published in top journals, including Nature, Science, and Cell, and has been featured in TIME, BBC, Scientific American, Discover, and other top media outlets. In 2021, Dr. Huberman launched the Huberman Lab podcast. The podcast is frequently ranked in the top 10 of all podcasts globally and is often ranked #1 in the categories of Science, Education, and Health & Fitness.

View all episodes from The Huberman Lab